Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McEwen Inc. (MUX) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, together with AI-assisted summaries to help interpret complex documents. As a Colorado corporation listed on the New York Stock Exchange, McEwen files current reports on Form 8-K and other periodic reports that describe material events affecting its gold, silver and copper business across the Americas.
In recent Form 8-K filings, McEwen has reported on a range of topics, including the business combination with Canadian Gold Corp. that added the Tartan Mine Project in Manitoba, the extension of the Environmental Impact Assessment for the El Gallo Mine in Mexico, and strategic investments such as the share exchange agreement to acquire an interest in Paragon Geochemical Laboratories. Other 8-Ks discuss financing transactions like flow-through share offerings, appointments of senior executives, and technical and feasibility milestones at the Los Azules copper project in San Juan, Argentina.
Through this page, users can review McEwen’s filings to see how the company describes its operations at the Gold Bar Mine Complex in Nevada, the Fox Complex in Ontario, the San José Mine in Argentina, the El Gallo Mine in Mexico and its 46.4% interest in McEwen Copper. AI-powered tools highlight key sections of lengthy filings, such as risk factor discussions, descriptions of material agreements, and summaries of technical and permitting developments.
Investors researching MUX can use the filings page to locate quarterly and annual reports when available (Forms 10-Q and 10-K), current reports on Form 8-K, and exhibits referenced in those filings. The inclusion of insider and financing-related disclosures, where filed, helps users understand equity issuances, ownership changes and other regulatory events that may influence the company’s capital structure and project funding.
William M. Shaver, who serves as Chief Operating Officer and a director of McEwen Inc. (MUX), was granted equity awards on 08/11/2025 consisting of a stock option and restricted stock units. The stock option gives the right to buy 80,000 shares at an exercise price of $10.43, vests in three equal annual installments beginning August 11, 2026, is exercisable through August 11, 2030, and is held directly. The restricted stock units total 6,300, represent the contingent right to one share (or cash at the issuer's discretion), and vest in three installments on December 29, 2025, June 29, 2026 and December 29, 2026.
The reported transactions are grants (acquisitions) rather than dispositions. Following the awards the filing shows beneficial ownership of 80,000 option interests and 6,300 RSUs held directly by Mr. Shaver. The disclosure is a routine insider compensation event providing equity linkage between management and common stock performance.
John Casimir Florek, a director of McEwen Inc. (MUX), was granted 10,000 stock options with an exercise price of $10.43. The transaction is recorded with an effective date of 08/11/2025. The options are classified as a stock option (right to buy) and are held directly by Mr. Florek following the reported transaction.
The award vests in three equal annual installments beginning 08/11/2026 and expires on 08/11/2030. In practical terms, the grant ties part of a director's potential compensation to the company's share price, while the staggered vesting delays any immediate exercise; full realization would require exercise at or above the $10.43 strike and would introduce up to 10,000 additional shares on exercise.
McEwen Inc. director Nicolas Darveau-Garneau was granted 20,000 stock options on 08/11/2025 with an exercise price of $10.43. The options give the right to buy common stock and are reported as held directly.
The grant vests in three equal annual installments beginning 08/11/2026 and includes an apparent expiration date of 08/11/2030. The filing lists the acquisition of 20,000 derivative securities (stock options) under the Form 4 disclosure.
McEwen Inc. (MUX) reported equity awards to its Chief Financial Officer, Perry Ing, reflecting a compensation grant recorded on 08/11/2025. The grant consists of 50,000 stock options with an exercise price of $10.43 and 5,600 restricted stock units (RSUs). After the reported transactions the reporting person beneficially owns 50,000 option rights and 5,600 RSU rights shown on the form as direct holdings.
The option award vests in three equal annual installments beginning August 11, 2026 and the option has an indicated expiration or last date of 08/11/2030. Each RSU represents a contingent right to one share (or cash at the issuer's discretion) and will vest in three approximately equal installments on December 29, 2025, June 29, 2026 and December 29, 2026. The Form 4 lists these as acquisitions (Transaction Code A) and identifies the awards as direct beneficial ownership.
Alfred Aguilar Colas, identified as a director of McEwen Inc. (MUX), acquired 10,000 stock options on 08/11/2025 with an exercise price of $10.43. The options cover 10,000 shares of common stock, are reported as directly beneficially owned following the transaction, and have an expiration date of 08/11/2030.
The filing states the options vest in three equal annual installments beginning 08/11/2026. The transaction is reported as an acquisition (code "A") and the form indicates it was filed by one reporting person.
Stephen Douglas Kaszas, a director of McEwen Inc. (MUX), was granted a stock option on 08/11/2025 to buy 10,000 shares of common stock at an exercise price of $10.43. The Form 4 reports the option as an acquisition and shows 10,000 derivative securities beneficially owned following the transaction, held directly. The option vests in three equal annual installments beginning August 11, 2026 and the option expires on August 11, 2030. The filing was made by one reporting person and identifies Kaszas relationship to the issuer as a director.
McEwen Inc. insider Robert Ross McEwen, who serves as Chief Executive Officer, a director and a greater-than-10% owner, was granted a stock option that gives him the right to buy 170,000 shares of McEwen Inc. common stock at an exercise price of $10.43 per share. The transaction is dated 08/11/2025 and the option expires on 08/11/2030. The options are documented as a stock option (right to buy) and are held directly by Mr. McEwen.
The grant vests in three equal annual installments beginning on 08/11/2026, which staggers exercisability over three years. Following the reported transaction, Mr. McEwen beneficially owns 170,000 options. The filing discloses standard Section 16 insider compensation activity without additional context on total outstanding shares or aggregate insider holdings in the filing text provided.
Jeffrey Chan, McEwen Inc.'s VP-Finance, reported equity awards dated 08/11/2025: a stock option to purchase 40,000 shares at an exercise price of $10.43 (expiration 08/11/2030) and 3,800 restricted stock units (RSUs). The option vests in three equal annual installments beginning 08/11/2026. The RSUs vest in three approximately equal installments on 12/29/2025, 06/29/2026 and 12/29/2026.
Each RSU represents a contingent right to one share of common stock or the cash value thereof as provided in the award agreement. Both grants are reported as direct beneficial ownership. The filing records compensation-related awards rather than open-market purchases or dispositions.
McEwen Inc. (MUX) director Michelle Makori was granted 20,000 stock options with an exercise price of $10.43 on 08/11/2025. The options are exercisable for common stock, held directly, and the grant leaves the reporting person with 20,000 derivative securities following the transaction.
The options vest in three equal annual installments beginning on August 11, 2026 and carry an expiration date of 08/11/2030. This filing records a standard equity grant to a director: it details the grant size, strike price, vesting schedule and expiration but contains no additional cash sales, purchases or other compensation adjustments.
McEwen Inc. reporting person Ian J. Ball, a director, acquired derivative securities in the form of stock options. The Form 4 shows an acquisition of 20,000 stock options with an exercise price of $10.43. The transaction date recorded is 08/11/2025, and the options vest in three equal annual installments beginning on August 11, 2026. The options have an expiration date listed as 08/11/2030 and are reported as directly owned following the transaction. The filing does not disclose any cash payment amount for the grant beyond the stated exercise price or any change in other holdings.
FAQ
What is the current stock price of McEwen (MUX)?
What is the market cap of McEwen (MUX)?
